V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)

NCT00109343 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1027

Enrollment

INDUSTRY

Sponsor class

Conditions

Measles
Mumps
Rubella
Varicella

Interventions

BIOLOGICAL: Comparator: ProQuad™ (V221)
BIOLOGICAL: Comparator: PREVNAR™ (pneumococcal 7-valent conjugate vaccine)

Sponsor

Merck Sharp & Dohme LLC